Promoted to associate in Jan 2023. Selected engagement experience:- Developed 4-year global strategy and individual global category strategies for consumer healthcare division of blue-chip consumer goods player (~$240bn market cap) - assessed product portfolio across all regions on ability to win and market attractiveness. Recommended which assets to double-down on and which to divest. Presented to senior leadership incl. Head of Strategy and CEO- Modelled M&A divestment of retail stores of leading UK pharmacy chain (~$70bn+ market cap) - Worked directly with the CFO and developed the pharmacy divestment model to inform sale prices and timing. Built adjacent business ramp down models and presented to senior stakeholders- ESG Strategy for a mid-tier UK bank (~€10bn+ market cap) – Led benchmarking assessment against other UK businesses and identified gaps in current strategy to propose initiatives to the Board- Independently wrote an investment thesis on carbon sequestration for a tier 1 automotive client (~$60bn market cap)Selected transaction experience (10+ due diligences) across multiple industries:- Sell-side CDD on leading European e-commerce logistics provider (~€2bn+ market cap) - Led bottom-up market model development- Buy-side CDD on European aviation assets (~€800m valuation) - Led revenue model development- Buy-side ODD on ~€20bn+ Healthcare carve-out from blue-chip European pharma player - Reportedly largest pharma deal of 2023 - Led value creation assessment- Buy-side CDD on UK construction equipment rental target - Led bottom-up market model development

Personal investment into early-stage companies such as Investa (Fintech) and Emerald (Healthtech)